Jazz Pharmaceuticals (JAZZ) Inventory Average (2011 - 2026)

Jazz Pharmaceuticals has reported Inventory Average for 16 years, with the latest figure at $427.2 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 12.2% year-over-year to $427.2 million; the trailing twelve-month figure through Mar 2026 stood at $427.2 million (down 12.2% YoY), and the FY2025 full-year result was $448.7 million, down 16.71% from the prior year.
• Inventory Average for Q1 2026 stood at $427.2 million, down from $450.1 million in the prior quarter.
• The five-year high for Inventory Average was $1.0 billion in Q1 2022, with the low at $427.2 million in Q1 2026.
• Average Inventory Average over 5 years is $624.9 million, with a median of $587.2 million recorded in 2024.
• Peak annual rise in Inventory Average reached 876.04% in 2022, while the deepest fall reached 34.76% in 2022.
• Tracing JAZZ's Inventory Average over 5 years: stood at $721.1 million in 2022, then dropped by 16.18% to $604.4 million in 2023, then dropped by 15.64% to $509.9 million in 2024, then slipped by 11.73% to $450.1 million in 2025, then declined by 5.07% to $427.2 million in 2026.
• The last three Inventory Average figures came in at $427.2 million (Q1 2026), $450.1 million (Q4 2025), and $494.0 million (Q3 2025), per Business Quant data.

Peer Comparison